Success Story: EB1A Approved Without RFE In 21 Days! We Helped a Human Immunology Specialist Secure Success with Premium Processing Service
Client’s Testimonial:
“Thank you for all your hard work and diligence in putting the paperwork together that made the application and subsequent approval process smooth.”
On September 16th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Principal Scientist in the Field of Human Immunology (Approval Notice).
General Field: Human Immunology
Position at the Time of Case Filing: Principal Scientist
Country of Origin: India
State of Residence at the Time of Filing: California
Approval Notice Date: September 16th, 2026
Processing Time: 21 days (Premium Processing Requested)
Case Summary:
Holding a Ph.D. in microbiology, the client serves as a senior scientist and is an established expert in human immunology. The client's research has received major federal support through funding from the National Institutes of Health (NIH).
To satisfy the rigorous requirements of the EB-1A (Alien of Extraordinary Ability) classification under the Kazarian framework, North America Immigration Law Group (Chen Immigration Law Associates) structured the petition around extensive objective evidence and strategic metric contextualization:
- 6,131 total citations accrued across a prolific publication record
- 34 peer-reviewed journal articles (7 first-authored), 11 conference abstracts (3 first-authored), 2 book chapters (1 first-authored), and 1 preprint
- At least 22 completed peer reviews for authoritative journals, alongside service on an editorial board and as a guest editor for leading venues
Rather than presenting citation metrics as self-evidently sufficient, our legal team provided a thorough bibliometric analysis to demonstrate how an adjudicator should interpret the client's extraordinary scientific standing. We established that the client ranks in the top 1% of most highly cited authors in immunology over the past decade, with an h-index placing the client in the top 4% of researchers in the field. Furthermore, at least 10 of the client's publications rank among the top 0.1% to top 10% most-cited immunology articles for their respective publication years, demonstrating extraordinary scientific influence.
The petition was further reinforced by 4 recommendation letters from internationally renowned experts in human immunology, who verified the client's sustained national and international acclaim. As one expert noted:
"In sum, it is apparent that [Client] has achieved a rare level of success in immunological research and that he merits every available opportunity to continue his work here."
By synthesizing the client's top-tier citation percentiles, prolific publication record, extensive peer-review and editorial leadership, major federal grant support, and widespread independent reliance into a cohesive final merits argument, NAILG successfully established the client's extraordinary ability. Filed under Direct Premium Processing, USCIS approved the I-140 EB-1A petition in just 21 days without a Request for Evidence (RFE), supporting the client's continued contributions to human immunology and translational immunoregulation in the United States.